Heart Transplant Rejection Breath Test Data Falls Short – CMS
This article was originally published in The Gray Sheet
Executive Summary
Medicare coverage of a breathalyzer test to detect heart transplant rejection is not warranted based on the current level of supporting data, CMS says
You may also be interested in...
It’s Final: No Medicare Coverage For Heart Transplant Rejection Test
Medicare will not cover Menssana Research's Heartsbreath heart transplant rejection test, CMS said Dec. 8
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.